Schedule 13D ownership disclosure

Spark Therapeutics, Inc.

Security class unavailable · CUSIP: 84652J103

Event date: 2015-01-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,118,576
Percent of class
8.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-007157
Form type
SC 13D
Filer
Sofinnova Venture Partners VIII, L.P.
CIK
CIK 1524064
Filed
Feb 09, 2015
Reporting period
Jan 29, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub